Product image of Latanoprost Stulln (Latanoprost) supplied by GNH India

Latanoprost Stulln

Active Ingredient:
Latanoprost
Origin:
EU

Latanoprost Stulln (Latanoprost)

Latanoprost, the active ingredient in Latanoprost Stulln, is a prostaglandin F2α analog presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure and is employed in the management of glaucoma and ocular hypertension. It is indicated for patients with elevated intra‑ocular pressure to prevent optic nerve damage.

GNH India supplies Latanoprost Stulln as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑compliant shipments to global markets.

Manufacturer / TM Owner

Pharma Stulln Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Latanoprost is used to reduce intra‑ocular pressure in several glaucoma‑related conditions.

  • Primary open‑angle glaucoma: lowers intra‑ocular pressure to slow optic nerve damage.
  • Ocular hypertension: reduces eye pressure to prevent progression to glaucoma.
  • Secondary open‑angle glaucoma: decreases intra‑ocular pressure to protect visual field.

How It Works

  • Latanoprost binds to prostaglandin F (FP) receptors in the ciliary body, activating a signaling cascade that remodels the extracellular matrix and enhances uveoscleral outflow of aqueous humor. The increased outflow reduces intra‑ocular pressure, helping to preserve optic nerve function in glaucoma patients.

Side Effects

Latanoprost may cause ocular and systemic reactions, most of which are mild and reversible.

Common Side Effects

  • Eye redness: mild conjunctival hyperemia.
  • Eye irritation: transient burning or stinging sensation.
  • Blurred vision: temporary visual disturbance after instillation.
  • Increased eyelash growth: longer, thicker lashes.
  • Darkening of iris: gradual increase in pigmentation.
  • Eye discomfort: sensation of foreign body.

Serious or Rare Side Effects

  • Severe allergic reaction: swelling, rash, or difficulty breathing.
  • Uveitis: inflammation of the uveal tract requiring medical attention.
  • Corneal edema: swelling of the cornea that may affect vision.
  • Persistent eye pain: ongoing discomfort beyond the initial period.
  • Vision loss: rare but serious deterioration of visual acuity.
  • Iris depigmentation: loss of iris color, potentially permanent.

Precautions & Warnings

Before initiating therapy with Latanoprost, consider the following safety measures.

  • Monitor intra‑ocular pressure: regular eye examinations are required to assess efficacy.
  • Avoid use in active ocular infection: may exacerbate the condition.
  • Do not combine with other prostaglandin analogs: risk of additive pressure‑lowering effect.
  • Caution in patients with a history of uveitis: may trigger inflammation.
  • Pregnancy and lactation: safety not established; use only if benefit outweighs risk.
  • Store at room temperature: keep in the original container, protect from light and moisture.

Avoid Interactions

Latanoprost can interact with other ophthalmic or systemic agents, influencing intra‑ocular pressure control.

Major Interactions (Avoid)

  • Non‑steroidal anti‑inflammatory eye drops: may reduce Latanoprost efficacy.
  • Systemic carbonic anhydrase inhibitors: additive IOP‑lowering effect may lead to hypotony.
  • Miotic agents: may counteract the pressure‑lowering action of Latanoprost.

Moderate Interactions (Monitor Closely)

  • Topical beta‑blocker eye drops: monitor for excessive pressure reduction.
  • Corticosteroid eye drops: may diminish response; regular IOP checks advised.
  • Herbal supplements affecting prostaglandin pathways: observe for changes in IOP control.

Frequently Asked Questions

Latanoprost Stulln is prescribed to lower intra‑ocular pressure in patients with primary open‑angle glaucoma, secondary open‑angle glaucoma, and ocular hypertension, helping to prevent optic nerve damage and preserve vision.

The active ingredient, latanoprost, activates prostaglandin F (FP) receptors in the eye, increasing uveoscleral outflow of aqueous humor. This enhanced drainage reduces intra‑ocular pressure, which is the primary therapeutic goal in glaucoma management.

The dosing regimen for Latanoprost Stulln is determined by the prescribing ophthalmologist. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact dose and frequency must follow the prescriber’s instructions.

Safety data for Latanoprost in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and strong IOP‑lowering efficacy. Compared with beta‑blockers or carbonic anhydrase inhibitors, prostaglandin analogs often provide greater pressure reduction with a favorable dosing convenience profile.

Latanoprost Stulln should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from light and moisture to maintain stability, and keep the bottle tightly closed when not in use.

The medication is administered as an ophthalmic solution. The patient should wash their hands, tilt the head back, pull down the lower eyelid, and place one drop into the conjunctival sac of the prescribed eye(s) once daily, usually in the evening.

Serious risks, though rare, include severe allergic reactions, uveitis, corneal edema, and significant vision loss. Patients should seek immediate medical attention if they experience sudden eye pain, redness, swelling, or any loss of vision.

Latanoprost Stulln is contraindicated in patients with known hypersensitivity to latanoprost or any component of the formulation, and it should be used with caution in individuals with active ocular infections, recent ocular surgery, or a history of uveitis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Latanoprost

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT